Search Results - "Malchair, Pierre"
-
1
Pulmonary Infections with Nontuberculous Mycobacteria, Catalonia, Spain, 1994-2014
Published in Emerging infectious diseases (01-06-2018)“…In Spain, systematic reporting of pulmonary infections with nontuberculous mycobacteria is not mandatory. Therefore, to determine trends, we retrospectively…”
Get full text
Journal Article -
2
Assessing sepsis-induced immunosuppression to predict positive blood cultures
Published in Frontiers in immunology (04-11-2024)“…Introduction Bacteremia is a life-threatening condition that can progress to sepsis and septic shock, leading to significant mortality in the emergency…”
Get full text
Journal Article -
3
A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)
Published in Current controlled trials in cardiovascular medicine (12-04-2022)“…COVID-19 has quickly become a global pandemic with a substantial number of deaths and is a considerable burden for healthcare systems worldwide. Although most…”
Get full text
Journal Article -
4
Hydroxychloroquine Myocardial Toxicity in a Patient with Systemic Lupus Erythematosus
Published in European journal of case reports in internal medicine (05-05-2015)“…Hydroxychloroquine is an antimalarial drug used in many rheumatologic and systemic diseases. Although considered by clinicians to be relatively safe, serious…”
Get full text
Journal Article -
5
Bayesian Analysis of the ICAT·COVID Randomized Clinical Trial
Published in Clinical therapeutics (01-02-2024)Get full text
Journal Article -
6
Bayesian Analysis of the ICAT·COVID Randomized Clinical Trial
Published in Clinical therapeutics (09-12-2023)Get full text
Journal Article -
7
Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia: A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial
Published in Clinical infectious diseases (24-05-2023)“…Abstract Background We aimed to evaluate icatibant, a competitive antagonist of the bradykinin B2 receptors, for the treatment of inpatients with coronavirus…”
Get full text
Journal Article -
8
Departments involved during the first episode of acute heart failure and subsequent emergency department revisits and rehospitalisations: an outlook through the NOVICA cohort
Published in European journal of heart failure (01-10-2019)“…Objectives We investigated the natural history of patients after a first episode of acute heart failure (FEAHF) requiring emergency department (ED)…”
Get full text
Journal Article -
9
Pulmonary infections with nontuberculous mycobacyteria, Catalonia, 1994-2014
Published in Emerging infectious diseases (01-06-2018)“…In Spain, systematic reporting of pulmonary infections with nontuberculous mycobacteria is not mandatory. Therefore, to determine trends, we retrospectively…”
Get full text
Journal Article -
10
Pulmonary infections with nontuberculous mycobacyteria, Catalonia, 1994-2014
Published in Emerging infectious diseases (01-06-2018)“…In Spain, systematic reporting of pulmonary infections with nontuberculous mycobacteria is not mandatory. Therefore, to determine trends, we retrospectively…”
Get full text
Journal Article -
11
Pulmonary infections with nontuberculous mycobacyteria, Catalonia, 1994-2014
Published in Emerging infectious diseases (01-06-2018)“…In Spain, systematic reporting of pulmonary infections with nontuberculous mycobacteria is not mandatory. Therefore, to determine trends, we retrospectively…”
Get full text
Journal Article -
12
A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2
Published in Trials (12-04-2022)“…Background COVID-19 has quickly become a global pandemic with a substantial number of deaths and is a considerable burden for healthcare systems worldwide…”
Get full text
Journal Article -
13
Revisit after discharge from the emergency department in a cohort of patients with COVID-19 pneumonia and analysis based on the healthcare resource used for follow-up. RESALSEVID study
Published in Journal of healthcare quality research (01-01-2023)“…COVID-19 pneumonia is a manifestation of SARS-CoV-2 infection and in most cases involves hospital admission. There are recommendations according to which these…”
Get more information
Journal Article -
14
The patient's experience: a new view of the emergency department?
Published in Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias (01-12-2023)Get more information
Journal Article -
15
Recommendations for the early diagnosis of suspected human immunodeficiency virus infection in the emergency department and the referral of patients for follow-up: a consensus statement of the Spanish Society of Emergency Medicine (SEMES)
Published in Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias (01-12-2020)“…Almost half of new diagnoses of human immunodeficiency virus (HIV) infection are made late, leading to increased morbidity and mortality, greater spread of…”
Get more information
Journal Article -
16
Exceptional treatment of COVID-19 pneumonia with icatibant
Published in Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias (01-04-2022)Get more information
Journal Article -
17
Predictors of revisits within 1 year by patients after acute COVID-19: the HUBCOVID365 cohort study
Published in Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias (01-02-2022)“…To analyze the frequencies of 3 types of hospital revisits by patients after treatment for COVID-19 in the emergency department. Retrospective observational…”
Get more information
Journal Article -
18
The patient’s experience: a new view of the emergency department?
Published in Emergencias (16-05-2024)Get full text
Journal Article